Filing Details

Accession Number:
0001209191-23-035263
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-07 21:32:14
Reporting Period:
2023-06-06
Accepted Time:
2023-06-07 21:32:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Biosciences Inc. PCRX Pharmaceutical Preparations (2834) 510619477
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1875723 Jonathan Slonin C/O Pacira Biosciences, Inc.
5401 West Kennedy Boulevard, Suite 890
Tampa FL 33609
Chief Clinical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-06-06 471 $38.99 36,813 No 4 S Direct
Common Stock Disposition 2023-06-07 490 $37.87 36,323 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
  2. Includes 205 shares of common stock acquired under the issuer's employee stock purchase plan in December 2022.